Consistent with the in vitro findings demonstrating compromised variant LG4–5 protein secretion, the expression of laminin α5 protein in GBM was greatly reduced (Figure 5, A and C), whereas the level of a GBM marker, nidogen-1, did not change. This evidence concerns the gene NID1 and glioblastoma.